Showing posts with label cannabis topicals. Show all posts
Showing posts with label cannabis topicals. Show all posts

Tuesday, February 3, 2015

What Cannabis Topical Balms Are Used For

CBD Oil as a balm to help with arthritis and pain as a medical marijuana treatment
CBD Oil Balm

Cannabis topicals are applied to the skin for direct application to the treatment area. Creams and balms can penetrate through the skin and body tissue. Patients use creams for treatment in arthritis, allergic skin reactions, post herpes neuralgia, muscle strains, inflammation and swelling. Topicals offer a non-phycho active medicine to the patient.

Research is limited on the many uses of cannabis topicals. Patients have been reported using topicals for many treatments including:

• Arthritis
• Dermatitis and psoriasis
• Wounds and cuts
• Muscle Pain
• Hemorrhoids
• Sore throat, bronchitis
• Menstrual cramping
• herpes, blisters and lip aid
• pain from sprains and breaks
• headaches
• breathing problems

Lotions and balms offer localized treatment to the targeted area. The cannabinoids work by targeting CB1 and CB2 receptors that are found all over the body including the skin. Most patients use this method for it's anti-inflammatory and pain relieving effects. Cannabis topicals often use a base of hemp oil which is rich in Omega 3 and 6. These essential fatty acids are beneficial for the health of your skin.

Source:

http://www.leafly.com/news/products/what-are-topicals-anyway-a-tour-of-a-manufacturing-lab

Friday, October 10, 2014

The Benefits of Cannabis for Glaucoma Treatment

Glaucoma is conditions in the eye that damages the optic nerve and can lead to blindness. The optic nerve carries visual information to the brain. Damage to the nerve is primarily caused by an increase of pressure to the eye, called intraocular pressure (IOP).(Source)

Cannabinoids found in cannabis have been successfully found to reduce intraocular pressure (IOP) and have neuroprotective properties. Helper and Frank in 1971 did a study that showed a 25-30% IOP and a reduction in blood pressure.(Source) An increase in usage of marijuana led to better tolerance, resulting a further reduction of IOP for patients that could take a higher dosage. (Source) A study by Dawson et al showed that long term use of marijuana of 10 years or more gave results as beginning users for reducing IOP, lowering the effectivness.(Source)

Studies have shown that cannabinoids work to reduce IOP at the localized eye area, not the central nervous system. Topical applications around the eye of cannabinoids show to reduce IOP the same amount as smoke or ingested. (Source) Cannabinoids effect the CB1 receptors, and these have been found in the ocular tissues, ciliary epithelium, the trabecular meshwork, Schlemm’s canal, ciliary muscle, ciliary body vessels, and retina. (Source) Cannabinoids also effect the CB2 receptors, but a study found that these receptors played no role in the IOP.(source)

Other theories about how cannabis reducing IOP have been researched, but not fully understood. The reduction of IOP does not seem to be from smoking cannabis resulting in lowering of the blood pressure.(Source) Studies have proposed however that the reduction in capillary pressure helps to reduce IOP. (Source) Sugrue did a study that showed that cannabinoids reduce the release of calcium which can help reduce IOP. (Source) Porcella et al also has a theory that cannabinoids acting as vasodilators by widening the blood vessels help to release the pressure on the eye. (Source)

Application of Cannabis for desired treatment of glaucoma has shown to be through smoking it, however for a non psychoactive method topical treatments are being developed. Unfortunately eye drops only deliver 5% of the medicine, due to the optical nerve being at the back of the eye. Other delivery methods are being researched with Porcella et al showing that cyclodextrins being the most effective thus far.(Source)

OUTCO in San Diego is the ONLY legal dispensary in San Diego and has a knowleageable staff.

Source:
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002587/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1772142/